Gustavo Torres-Cifuentes, MD
Vascular Surgery · Montebello, CANPI 1225138498
Payments from drug & device makers
What this record shows
This record is dominated by other: $8,100 of the $9,175 with a category attached, or 88.3%. Acera Surgical, Inc. accounts for 89.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $8,203 and has fallen 97.1% since, to $239 in 2025.
Across 30 payments — averaging $305.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acera Surgical, Inc.$8K
- Siemens Medical Solutions USA, Inc.$194
- Genentech USA, Inc.$146
- Koya Medical, Inc.$126
- Endologix LLC$103
- Boston Scientific$88
- plus $302 from 9 others
What the payments were for
- Food & beverage$1,07512%
- Other$8,10088%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acera Surgical, Inc. | 6 | $8,215 |
| Siemens Medical Solutions USA, Inc. | 3 | $194 |
| Genentech USA, Inc. | 1 | $146 |
| Koya Medical, Inc. | 1 | $126 |
| Endologix LLC | 1 | $103 |
| Boston Scientific | 4 | $88 |
| Smith+Nephew | 4 | $72 |
| AbbVie | 2 | $49 |
| BD | 1 | $33 |
| Lemaitre Vascular, Inc. | 2 | $32 |
| Angiodynamics, Inc. | 1 | $30 |
| Merit Medical Systems Inc | 1 | $24 |
| Cordis US CORP. | 1 | $22 |
| Mimedx Group, Inc. | 1 | $21 |
| Abbott | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Restrata Wound Matrix$8,100
- Dayspring$379
- Cios Alpha$140
- Koya Medical$126
- Alto Abdominal Stent Graft System$103
How this compares
$9,175 in reported general payments places this provider in the 65th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 34 | $1,725 |
| ClopidogrelClopidogrel Bisulfate | 19 | $221 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 27 | $66 |
| Levofloxacin | 14 | $43 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Montebello
- Son DuongFountain Valley$503K
- Venita ChandraPalo Alto$488K
- Sukgu HanLos Angeles$477K
- Leigh Ann ObanionFresno$469K
- Trevor DerderianRancho Mirage$359K
- Karthikeshwar KasirajanPalo Alto$349K
- Johnathon RolloLos Angeles$337K
- Melissa LojaFairfield$272K
- Jason LeePalo Alto$228K
- John LaneSan Diego$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.